Inactive Instrument

HOYA Corporation Share Price Other OTC

Equities

HOCPY

US4432511032

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 760B 4.88B 408B Sales 2025 * 816B 5.24B 438B Capitalization 6,344B 40.72B 3,401B
Net income 2024 * 173B 1.11B 92.53B Net income 2025 * 197B 1.27B 106B EV / Sales 2024 * 7.76 x
Net cash position 2024 * 449B 2.88B 240B Net cash position 2025 * 478B 3.07B 256B EV / Sales 2025 * 7.19 x
P/E ratio 2024 *
36.9 x
P/E ratio 2025 *
31.9 x
Employees -
Yield 2024 *
0.64%
Yield 2025 *
0.69%
Free-Float 98.65%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 01/92/01
Director of Finance/CFO 50 01/02/01
Director/Board Member 65 01/85/01
Members of the board TitleAgeSince
Director/Board Member 67 01/18/01
Director/Board Member 65 01/85/01
Director/Board Member 76 01/13/01
More insiders
Hoya Corporation specialises in the manufacture and commercialisation of optical products. Net sales break down by business segment as follows: - health (66%): manufacturing of health care products (75.4% of sales; eyeglass lenses and contact lenses) and medical products (24.6%; endoscopes, medical accessories, intraocular lenses, artificial bones and metal implants for orthopedics); - information technology (33.1%): manufacturing of electronic products (78.2% of sales; photomasks for semiconductors, masks and devices for LCD screens and hard disks) and imaging products (21.8%; optical lenses, optical glasses and laser equipment); - other (0.9%). Net sales are distributed geographically as follows: Japan (28.9%), China (8.2%), Asia (24.7%), Europe (19.3%), the United States (15.1%), the Americas (2.4%) and others (1.4%).
Calendar
Related indices
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW